ULK2 antibody [C2C3], C-term
|Applications||ICC/IF, IHC-P, WB|
Not tested in other applications.
|IHC (Formalin-fixed paraffin-embedded sections)||1:100-1:1000*
*Optimal dilutions/concentrations should be determined by the researcher.
|Predicted Target Size||113 kDa (note)
|Positive Controls||293T , A431 , HeLa , HepG2 , NT2D1 , NIH-3T3|
(Please refer to the vial label for the specific concentration)|
|Purification||Purified by antigen-affinity chromatography.|
|Full Name||unc-51-like kinase 2 (C. elegans)|
|Product Description||Rabbit Polyclonal antibody to ULK2 (serine/threonine-protein kinase ULK2)|
|Background||This gene encodes a protein that is similar to a serine/threonine kinase in C. elegans which is involved in axonal elongation. The structure of this protein is similar to the C. elegans protein in that both proteins have an N-terminal kinase domain, a central proline/serine rich (PS) domain, and a C-terminal (C) domain. The gene is located within the Smith-Magenis syndrome region on chromosome 17. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq]|
|Synonyms||ATG1B antibody, KIAA0623 antibody, Unc51.2 antibody, ULK2 antibody, serine/threonine-protein kinase ULK2 antibody, unc-51-like kinase 2 (C. elegans) antibody|
|Immunogen||Recombinant protein encompassing a sequence within the C-terminus region of human ULK2. The exact sequence is proprietary.|
|Species Reactivity||Human, Mouse|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Predict Reactivity Note||Rat (95%)|